Condition
Mesothelioma
Estimated Enrollment: 200
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: UNOLE 0329
Study First Received: May 9, 2014
Last Updated: April 7, 2017
Estimated Primary Completion Date: March 1, 2018
Primary Outcome Measures:
Overall Survival|Progression Free Survival|Number of serious adverse events reported|BRCA1 status in blood and tumour samples
Sponsors and Collaborators:
Wales Cancer Trials Unit|Pierre Fabre Laboratories
Website Link: https://ClinicalTrials.gov/show/NCT02139904
